John C. Martin, Director at Kronos Bio, Inc. (KRON), bought 1,195,393 shares at $19.00 ($4.8M) on 2020-10-14, disclosed to the SEC on 2020-10-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 914,333 | $0 | 0.0% |
| 2 | $16.15 | 205,260 | $3.3M | 69.7% |
| 3 | $19.00 | 75,800 | $1.4M | 30.3% |
| Total | $3.98 avg | 1,195,393 | $4.8M | 100% |
| Filing → |
| GILD | SELL | 2018-10-03 | $5.2M | — | Filing → |
| GILD | SELL | 2018-09-06 | $7.2M | — | Filing → |
| GILD | SELL | 2018-08-03 | $7.8M | — | Filing → |